Tapewire

Nasdaq · USD

SYNA

SYNAPTICS Inc

Export transactions ↓
Tapewire entity
4089
SEC CIK
0000817720
Parsed reports
568

Last 12 months

Inside the activity.

0 purchase rows · 58 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202508
Jan 202605
Feb 202603
Mar 202601
Apr 202606
May 202609
Jun 202602
Jul 202608
Aug 2026012
Sep 202604
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 05, 2021 Filed Jan 6, 2021 22:51 UTC
NOLAN KERMITSee Remarks
Exercise / conversionCommon Stock · Derivative 1,049 $0.00 Strike: $89.29 $0.00
Disclosure

SEC source: 0001209191-21-002305 · doc4.xml · derivative · entry 3

NOLAN KERMIT · CIK 0001767271 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,049 shares

Expires 2022-10-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the October 23, 2015 date of grant, until fully vested on October 23, 2018.

Read SEC document
January 05, 2021 Filed Jan 6, 2021 22:51 UTC
NOLAN KERMITSee Remarks
SaleCommon Stock 1,049 $100.00 $104,900.00
Disclosure

SEC source: 0001209191-21-002305 · doc4.xml · nonDerivative · entry 2

NOLAN KERMIT · CIK 0001767271 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,711

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020.

Read SEC document
January 05, 2021 Filed Jan 6, 2021 22:51 UTC
NOLAN KERMITSee Remarks
Exercise / conversionCommon Stock 1,049 $89.29 $93,665.21
Disclosure

SEC source: 0001209191-21-002305 · doc4.xml · nonDerivative · entry 1

NOLAN KERMIT · CIK 0001767271 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,760

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 30, 2020 Filed Jan 4, 2021 15:05 UTC
NOLAN KERMITSee Remarks
Exercise / conversionCommon Stock · Derivative 408 $0.00 Strike: $79.38 $0.00
Disclosure

SEC source: 0001209191-21-000045 · doc4.xml · derivative · entry 5

NOLAN KERMIT · CIK 0001767271 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 408 shares

Expires 2022-07-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the July 31, 2015 date of grant, until fully vested on July 31, 2018.

Read SEC document
December 30, 2020 Filed Jan 4, 2021 15:05 UTC
NOLAN KERMITSee Remarks
Exercise / conversionCommon Stock · Derivative 408 $0.00 Strike: $85.69 $0.00
Disclosure

SEC source: 0001209191-21-000045 · doc4.xml · derivative · entry 4

NOLAN KERMIT · CIK 0001767271 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 408 shares

Expires 2022-04-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the April 24, 2015 date of grant, until fully vested on April 24, 2018.

Read SEC document
December 30, 2020 Filed Jan 4, 2021 15:05 UTC
NOLAN KERMITSee Remarks
SaleCommon Stock 7,261 $95.00 $689,795.00
Disclosure

SEC source: 0001209191-21-000045 · doc4.xml · nonDerivative · entry 3

NOLAN KERMIT · CIK 0001767271 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,711

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020.

Read SEC document
December 30, 2020 Filed Jan 4, 2021 15:05 UTC
NOLAN KERMITSee Remarks
Exercise / conversionCommon Stock 408 $79.38 $32,387.04
Disclosure

SEC source: 0001209191-21-000045 · doc4.xml · nonDerivative · entry 2

NOLAN KERMIT · CIK 0001767271 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,972

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 30, 2020 Filed Jan 4, 2021 15:05 UTC
NOLAN KERMITSee Remarks
Exercise / conversionCommon Stock 408 $85.69 $34,961.52
Disclosure

SEC source: 0001209191-21-000045 · doc4.xml · nonDerivative · entry 1

NOLAN KERMIT · CIK 0001767271 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,564

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 28, 2020 Filed Dec 29, 2020 22:43 UTC
NOLAN KERMITSee Remarks
Exercise / conversionCommon Stock · Derivative 745 $0.00 Strike: $78.11 $0.00
Disclosure

SEC source: 0001209191-20-065392 · doc4.xml · derivative · entry 3

NOLAN KERMIT · CIK 0001767271 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 745 shares

Expires 2021-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the August 1, 2014 date of grant, until fully vested on August 1, 2017.

Read SEC document
December 28, 2020 Filed Dec 29, 2020 22:43 UTC
NOLAN KERMITSee Remarks
SaleCommon Stock 5,745 $90.00 $517,050.00
Disclosure

SEC source: 0001209191-20-065392 · doc4.xml · nonDerivative · entry 2

NOLAN KERMIT · CIK 0001767271 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,156

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020.

Read SEC document
December 28, 2020 Filed Dec 29, 2020 22:43 UTC
NOLAN KERMITSee Remarks
Exercise / conversionCommon Stock 745 $78.11 $58,191.95
Disclosure

SEC source: 0001209191-20-065392 · doc4.xml · nonDerivative · entry 1

NOLAN KERMIT · CIK 0001767271 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,901

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 28, 2020 Filed Dec 29, 2020 22:39 UTC SaleCommon Stock 5,000 $90.00 $450,000.00
Disclosure

SEC source: 0001209191-20-065391 · doc4.xml · nonDerivative · entry 1

BUCHANAN JEFFREY D · CIK 0001247555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,148

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 24, 2020.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:38 UTC
Awsare SaleelSee Remarks
SaleCommon Stock 139 $79.60 $11,064.40
Disclosure

SEC source: 0001209191-20-058987 · doc4.xml · nonDerivative · entry 1

Awsare Saleel · CIK 0001733464 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,308

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020, as amended by that certain First Amendment dated March 13, 2020.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:18 UTC
McFarland JohnSVP, General Counsel & Sec.
SaleCommon Stock 300 $84.50 $25,348.50
Disclosure

SEC source: 0001209191-20-057779 · doc4.xml · nonDerivative · entry 4

McFarland John · CIK 0001486742 · SVP, General Counsel & Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,860

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.49 to $84.50, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:18 UTC
McFarland JohnSVP, General Counsel & Sec.
SaleCommon Stock 4,383 $83.38 $365,472.95
Disclosure

SEC source: 0001209191-20-057779 · doc4.xml · nonDerivative · entry 3

McFarland John · CIK 0001486742 · SVP, General Counsel & Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,160

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.00 to $83.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:18 UTC
McFarland JohnSVP, General Counsel & Sec.
SaleCommon Stock 2,097 $82.41 $172,805.17
Disclosure

SEC source: 0001209191-20-057779 · doc4.xml · nonDerivative · entry 2

McFarland John · CIK 0001486742 · SVP, General Counsel & Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,543

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.00 to $82.95, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:18 UTC
McFarland JohnSVP, General Counsel & Sec.
SaleCommon Stock 3,695 $81.60 $301,510.89
Disclosure

SEC source: 0001209191-20-057779 · doc4.xml · nonDerivative · entry 1

McFarland John · CIK 0001486742 · SVP, General Counsel & Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,640

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.99, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:15 UTC SaleCommon Stock 376 $83.50 $31,396.00
Disclosure

SEC source: 0001209191-20-057778 · doc4.xml · nonDerivative · entry 1

HARDMAN SUSAN J · CIK 0001185652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,955

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated August 10, 2020.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:12 UTC
Awsare SaleelSee Remarks
SaleCommon Stock 300 $84.49 $25,347.00
Disclosure

SEC source: 0001209191-20-057775 · doc4.xml · nonDerivative · entry 4

Awsare Saleel · CIK 0001733464 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,447

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.47 to $84.50, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:12 UTC
Awsare SaleelSee Remarks
SaleCommon Stock 3,112 $83.43 $259,648.48
Disclosure

SEC source: 0001209191-20-057775 · doc4.xml · nonDerivative · entry 3

Awsare Saleel · CIK 0001733464 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,747

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.12 to $83.92, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:12 UTC
Awsare SaleelSee Remarks
SaleCommon Stock 1,720 $82.58 $142,045.34
Disclosure

SEC source: 0001209191-20-057775 · doc4.xml · nonDerivative · entry 2

Awsare Saleel · CIK 0001733464 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,859

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.11 to $83.08, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:12 UTC
Awsare SaleelSee Remarks
SaleCommon Stock 3,364 $81.61 $274,528.30
Disclosure

SEC source: 0001209191-20-057775 · doc4.xml · nonDerivative · entry 1

Awsare Saleel · CIK 0001733464 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,579

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.10 to $82.09, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:10 UTC SaleCommon Stock 300 $83.50 $25,050.00
Disclosure

SEC source: 0001209191-20-057773 · doc4.xml · nonDerivative · entry 1

Allgood Kiva A. · CIK 0001778208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,026

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2020.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:08 UTC SaleCommon Stock 200 $84.49 $16,898.00
Disclosure

SEC source: 0001209191-20-057771 · doc4.xml · nonDerivative · entry 4

Butler Dean Warren · CIK 0001791047 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,534

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2020.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:08 UTC SaleCommon Stock 2,233 $83.43 $186,293.61
Disclosure

SEC source: 0001209191-20-057771 · doc4.xml · nonDerivative · entry 3

Butler Dean Warren · CIK 0001791047 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,734

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.13 to $83.90, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:08 UTC SaleCommon Stock 1,942 $82.61 $160,420.46
Disclosure

SEC source: 0001209191-20-057771 · doc4.xml · nonDerivative · entry 2

Butler Dean Warren · CIK 0001791047 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,967

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.09 to $83.07, inclusive. The reporting person undertakes to provide to the Company , any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:08 UTC SaleCommon Stock 2,939 $81.66 $239,989.34
Disclosure

SEC source: 0001209191-20-057771 · doc4.xml · nonDerivative · entry 1

Butler Dean Warren · CIK 0001791047 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,909

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.09 to $82.04, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
November 02, 2020 Filed Nov 4, 2020 17:30 UTC GrantCommon Stock 2,467 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-056843 · doc4.xml · nonDerivative · entry 1

HARDMAN SUSAN J · CIK 0001185652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,331

F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2021, or for a Director not standing for re-election, the date of the Issuer's 2021 Annual Meeting of Stockholders.

Read SEC document
November 02, 2020 Filed Nov 4, 2020 17:26 UTC
Chan NelsonDirector
GrantCommon Stock 2,467 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-056842 · doc4.xml · nonDerivative · entry 1

CHAN NELSON C · CIK 0001242653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,210

F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2021, or for a Director not standing for re-election, the date of the Issuer's 2021 Annual Meeting of Stockholders.

Read SEC document
November 02, 2020 Filed Nov 4, 2020 17:23 UTC GrantCommon Stock 2,467 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-056839 · doc4.xml · nonDerivative · entry 1

GEESLIN KEITH · CIK 0001196198 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,863

F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2021, or for a Director not standing for re-election, the date of the Issuer's 2021 Annual Meeting of Stockholders.

Read SEC document
November 02, 2020 Filed Nov 4, 2020 17:20 UTC
Whims JamesDirector
GrantCommon Stock 2,467 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-056838 · doc4.xml · nonDerivative · entry 1

WHIMS JAMES L · CIK 0001216815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,229

F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2021, or for a Director not standing for re-election, the date of the Issuer's 2021 Annual Meeting of Stockholders.

Read SEC document
November 02, 2020 Filed Nov 4, 2020 17:18 UTC GrantCommon Stock 2,467 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-056836 · doc4.xml · nonDerivative · entry 1

BUCHANAN JEFFREY D · CIK 0001247555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,148

F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2021, or for a Director not standing for re-election, the date of the Issuer's 2021 Annual Meeting of Stockholders.

Read SEC document
November 02, 2020 Filed Nov 4, 2020 17:12 UTC GrantCommon Stock 2,467 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-056835 · doc4.xml · nonDerivative · entry 1

Allgood Kiva A. · CIK 0001778208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,326

F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2021, or for a Director not standing for re-election, the date of the Issuer's 2021 Annual Meeting of Stockholders.

Read SEC document
October 31, 2020 Filed Nov 3, 2020 22:51 UTC
HURLSTON MICHAEL E.Director · See remarks below
Tax withholdingCommon Stock 6,424 $76.67 $492,528.08
Disclosure

SEC source: 0001209191-20-056724 · doc4.xml · nonDerivative · entry 3

HURLSTON MICHAEL E. · CIK 0001573338 · Director · See remarks below

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,362

F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units.

Read SEC document
October 31, 2020 Filed Nov 3, 2020 22:51 UTC
HURLSTON MICHAEL E.Director · See remarks below
Tax withholdingCommon Stock 12,846 $76.67 $984,902.82
Disclosure

SEC source: 0001209191-20-056724 · doc4.xml · nonDerivative · entry 2

HURLSTON MICHAEL E. · CIK 0001573338 · Director · See remarks below

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,786

F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units.

Read SEC document
October 31, 2020 Filed Nov 3, 2020 22:51 UTC
HURLSTON MICHAEL E.Director · See remarks below
GrantCommon Stock 24,540 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-056724 · doc4.xml · nonDerivative · entry 1

HURLSTON MICHAEL E. · CIK 0001573338 · Director · See remarks below

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 286,632

F1 · shares: Reflects shares released in connection with the vesting of performance-based market stock units granted on October 31, 2019.

Read SEC document
October 31, 2020 Filed Nov 3, 2020 22:48 UTC Tax withholdingCommmon Stock 7,137 $76.67 $547,193.79
Disclosure

SEC source: 0001209191-20-056721 · doc4.xml · nonDerivative · entry 2

Butler Dean Warren · CIK 0001791047 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,848

F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units.

Read SEC document
October 31, 2020 Filed Nov 3, 2020 22:48 UTC GrantCommon Stock 13,634 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-056721 · doc4.xml · nonDerivative · entry 1

Butler Dean Warren · CIK 0001791047 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,985

F1 · shares: Reflects shares released in connection with the vesting of performance-based market stock units granted on October 31, 2019.

Read SEC document
October 31, 2020 Filed Nov 3, 2020 22:45 UTC
Awsare SaleelSee Remarks
Tax withholdingCommon Stock 5,023 $76.67 $385,113.41
Disclosure

SEC source: 0001209191-20-056720 · doc4.xml · nonDerivative · entry 3

Awsare Saleel · CIK 0001733464 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,943

F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units.

Read SEC document
October 31, 2020 Filed Nov 3, 2020 22:45 UTC
Awsare SaleelSee Remarks
Tax withholdingCommon Stock 5,231 $76.67 $401,060.77
Disclosure

SEC source: 0001209191-20-056720 · doc4.xml · nonDerivative · entry 2

Awsare Saleel · CIK 0001733464 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,966

F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units.

Read SEC document
October 31, 2020 Filed Nov 3, 2020 22:45 UTC
Awsare SaleelSee Remarks
GrantCommon Stock 9,993 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-056720 · doc4.xml · nonDerivative · entry 1

Awsare Saleel · CIK 0001733464 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,197

F1 · shares: Reflects shares released in connection with the vesting of performance-based market stock units granted on December 13, 2017 and October 31, 2019.

Read SEC document
October 31, 2020 Filed Nov 3, 2020 22:39 UTC
McFarland JohnSVP, General Counsel & Sec.
Tax withholdingCommon Stock 5,236 $76.67 $401,444.12
Disclosure

SEC source: 0001209191-20-056717 · doc4.xml · nonDerivative · entry 3

McFarland John · CIK 0001486742 · SVP, General Counsel & Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,335

F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units.

Read SEC document
October 31, 2020 Filed Nov 3, 2020 22:39 UTC
McFarland JohnSVP, General Counsel & Sec.
Tax withholdingCommon Stock 6,266 $76.67 $480,414.22
Disclosure

SEC source: 0001209191-20-056717 · doc4.xml · nonDerivative · entry 2

McFarland John · CIK 0001486742 · SVP, General Counsel & Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,571

F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units.

Read SEC document
October 31, 2020 Filed Nov 3, 2020 22:39 UTC
McFarland JohnSVP, General Counsel & Sec.
GrantCommon Stock 11,971 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-056717 · doc4.xml · nonDerivative · entry 1

McFarland John · CIK 0001486742 · SVP, General Counsel & Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,837

F1 · shares: Reflects shares released in connection with the vesting of performance-based market stock units granted on October 31, 2017, November 13, 2018 and October 31, 2019.

Read SEC document
October 31, 2020 Filed Nov 3, 2020 22:33 UTC
NOLAN KERMITSee Remarks
Tax withholdingCommon Stock 3,323 $76.67 $254,774.41
Disclosure

SEC source: 0001209191-20-056711 · doc4.xml · nonDerivative · entry 3

NOLAN KERMIT · CIK 0001767271 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,156

F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units.

Read SEC document
October 31, 2020 Filed Nov 3, 2020 22:33 UTC
NOLAN KERMITSee Remarks
Tax withholdingCommon Stock 2,175 $76.67 $166,757.25
Disclosure

SEC source: 0001209191-20-056711 · doc4.xml · nonDerivative · entry 2

NOLAN KERMIT · CIK 0001767271 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,479

F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units.

Read SEC document
October 31, 2020 Filed Nov 3, 2020 22:33 UTC
NOLAN KERMITSee Remarks
GrantCommon Stock 4,498 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-056711 · doc4.xml · nonDerivative · entry 1

NOLAN KERMIT · CIK 0001767271 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,654

F1 · shares: Reflects shares released in connection with the vesting of performance-based market stock units granted on December 13, 2017 and October 31, 2019.

Read SEC document
October 21, 2020 Filed Oct 23, 2020 17:28 UTC Tax withholdingCommon Stock 2,685 $78.98 $212,061.30
Disclosure

SEC source: 0001209191-20-055652 · doc4.xml · nonDerivative · entry 1

Butler Dean Warren · CIK 0001791047 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,351

F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units.

Read SEC document
October 09, 2020 Filed Oct 13, 2020 21:16 UTC
McFarland JohnSVP, General Counsel & Sec.
SaleCommon Stock 1,403 $83.41 $117,022.55
Disclosure

SEC source: 0001209191-20-054680 · doc4.xml · nonDerivative · entry 2

McFarland John · CIK 0001486742 · SVP, General Counsel & Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,866

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.35 to $83.49, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 09, 2020 Filed Oct 13, 2020 21:16 UTC
McFarland JohnSVP, General Counsel & Sec.
SaleCommon Stock 7,811 $82.92 $647,717.80
Disclosure

SEC source: 0001209191-20-054680 · doc4.xml · nonDerivative · entry 1

McFarland John · CIK 0001486742 · SVP, General Counsel & Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,269

F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.35 to $83.34, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.